
Sign up to save your podcasts
Or


Plus, a federal appeals court denies the Trump administration’s bid to avoid fully funding SNAP benefits for November. And Novo Nordisk’s shares gain after the drugmaker withdraws from a bidding war over the obesity drug maker Metsera. Caitlin McCabe hosts.
Sign up for WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By The Wall Street Journal4.2
652652 ratings
Plus, a federal appeals court denies the Trump administration’s bid to avoid fully funding SNAP benefits for November. And Novo Nordisk’s shares gain after the drugmaker withdraws from a bidding war over the obesity drug maker Metsera. Caitlin McCabe hosts.
Sign up for WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices

2,851 Listeners

1,713 Listeners

4,420 Listeners

406 Listeners

427 Listeners

1,649 Listeners

1,448 Listeners

1,044 Listeners

1,320 Listeners

6,097 Listeners

1,573 Listeners

212 Listeners

1,322 Listeners

586 Listeners

151 Listeners

87 Listeners

80 Listeners

150 Listeners